Moving Biotech (4MB), a clinical-stage biotechnology company dedicated to developing first-in-class therapies for inflammatory knee osteoarthritis, today announced the completion of patient enrollment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results